Paeoniflorin as a candidate disease-modifying therapy for diabetic peripheral neuropathy: mechanisms, exposure challenges, and translational priorities.
Saved in:
| Title: | Paeoniflorin as a candidate disease-modifying therapy for diabetic peripheral neuropathy: mechanisms, exposure challenges, and translational priorities. |
|---|---|
| Authors: | Liu YN; Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China., Jia SY; Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China., Zhou LS; Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China., Tang XJ; Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China., Ming Z; Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China., Su Y; Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China., Lin JY; Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Apr 13; Vol. 17, pp. 1751578. Date of Electronic Publication: 2026 Apr 13 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
